Cervical cancer and cervical screening

Authors

  • О. В. Рыкова Medical Laboratory «Synevo», Ukraine

DOI:

https://doi.org/10.18370/2309-4117.2014.20.85-88

Keywords:

cervical cancer, cervical screening, traditional cytology, liquid-based cytology, Pap-test, The Bethesda System

Abstract

The paper presents the modern laboratory aspects of cytology in the framework of an effective cervical screening: factors affecting the quality of cytology, comparing conventional and liquidbased cytology, standardization issue opinions cytology according to the Bethesda system (The Bethesda system).
The combination of cytology with HPV testing enables the clinician to identify and treated the initial, pre-cancerous stage in time, and also enables to reduce morbidity and mortality from cervical cancer in women in Ukraine

Author Biography

О. В. Рыкова, Medical Laboratory «Synevo»

Head of the clinical direction of laboratory diagnosis

References

Herbert, A., Bergeron, C., Wiener, H., Schenck, U., Klinkhamer, P., Bulten, J., Arby, M. “European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology”. Cytopathology, 18(2007): 213-219.

Arbyn, M., Anttila, A., Jordan, J., Ronco, G., Schenck, U., Segnan, N., Wiener, H.G., Herbert, A., Daniel, J. (technical editor), von Karsa, L. European guidelines for quality assurance in cervical cancer screening. Second Edition (2008).

World Health Organization. “Comprehensive Cervical Cancer Control.” A guide to essential practice (2010), http://whqlibdoc. who.int/publications/2006/9241547006_eng.pdf?ua=1.

Published

2014-12-19

Issue

Section

Tumors and pretumoral pathology

Most read articles by the same author(s)